Evidence map›Paper›PMID 27398080›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2016

Metabolomics meets functional assays: coupling LC-MS and microfluidic cell-based receptor-ligand analyses.

M G L Henquet, M Roelse, R C H de Vos, A Schipper, G Polder, N C A de Ruijter, R D Hall, M A Jongsma

Open access · hybridAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

M G L Henquet *BU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
M Roelse *BU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
R C H de VosBU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
A SchipperBU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
G PolderBU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
N C A de RuijterLaboratory of Cell Biology, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
R D HallBU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
M A JongsmaBU Bioscience, WageningenUR, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.
Wageningen University & Research · NLCentre for BioSystems Genomics · NLGraduate School Experimental Plant Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMetabolomics has become a valuable tool in many research areas. However, generating metabolomics-based biochemical profiles without any related bioactivity is only of indirect value in understanding a biological process. Therefore, metabolomics research could greatly benefit from tools that directly determine the bioactivity of the detected compounds.

objectiveWe aimed to combine LC-MS metabolomics with a cell based receptor assay. This combination could increase the understanding of biological processes and may provide novel opportunities for functional metabolomics.

methodsWe developed a flow through biosensor with human cells expressing both the TRPV1, a calcium ion channel which responds to capsaicin, and the fluorescent intracellular calcium ion reporter, YC3.6. We have analysed three contrasting

resultsAmong the compounds in the crude pepper fruit extracts, we confirmed capsaicin and also identified both nordihydrocapsaicin and dihydrocapsaicin as true agonists of the TRPV1 receptor. Furthermore, the biosensor was able to detect receptor activity in extracts of both

conclusionOur results demonstrate that the TRPV1 biosensor is suitable for detecting bioactive metabolites. Novel opportunities may lie in the development of a continuous functional assay, where the biosensor is directly coupled to the LC-MS.

Indexed as

BioactivityCapsaicinFunctional metabolomicsReceptor-ligand screeningTRPV1

Identifiers

PMID27398080
PMCPMC4917570
OpenAlexW2470106831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.